Not checked for notices yet.
The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.
Robert J Moots, Ricardo M Xavier, Chi Chiu Mok and 11 more
PLoS ONE · 2017
doi:10.1371/journal.pone.0175207
Cited by papers we hold 4
- Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies · 2021No notice
- Durable and controlled depletion of neutrophils in mice · 2020No notice
- Immunogenicity of TNF-Inhibitors · 2020No notice
- Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.